Novel anticoagulants versus vitamin K antagonists for cardioversion of non- valvular atrial fibrillation – a meta-analysis of more than 17000 patients

Non-vitamin K antagonist oral anticoagulants (NOACs) have proven a favorable risk-benefit profile compared to vitamin K antagonists (VKAs) for preventing stroke and systemic embolism in patients with non-valvular atrial fibrillation (AF), but actual data are not sufficiently powered to extend this p...

Descripción completa

Detalles Bibliográficos
Autores principales: Mincu, Raluca Ileana, Mahabadi, Amir Abbas, Totzeck, Matthias, Rassaf, Tienush
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6395612/
https://www.ncbi.nlm.nih.gov/pubmed/30816247
http://dx.doi.org/10.1038/s41598-019-39925-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6395612/
https://www.ncbi.nlm.nih.gov/pubmed/30816247
http://dx.doi.org/10.1038/s41598-019-39925-5

Ejemplares similares